TDOC Teladoc Health Inc

Price (delayed)

$19.125

Market cap

$3.15B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$24.78

Enterprise value

$3.77B

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals ...

Highlights
The company's EPS has surged by 60% YoY and by 43% QoQ
TDOC's net income has surged by 59% year-on-year and by 43% since the previous quarter
Teladoc Health's equity has shrunk by 62% YoY

Key stats

What are the main financial stats of TDOC
Market
Shares outstanding
164.95M
Market cap
$3.15B
Enterprise value
$3.77B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.36
Price to sales (P/S)
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.49
Earnings
Revenue
$2.53B
EBIT
-$4.02B
EBITDA
-$3.72B
Free cash flow
$63.62M
Per share
EPS
-$24.78
Free cash flow per share
$0.39
Book value per share
$14.02
Revenue per share
$15.42
TBVPS
$8.89
Balance sheet
Total assets
$4.32B
Total liabilities
$2.02B
Debt
$1.57B
Equity
$2.3B
Working capital
$937.57M
Liquidity
Debt to equity
0.69
Current ratio
3.45
Quick ratio
3.06
Net debt/EBITDA
-0.17
Margins
EBITDA margin
-147.1%
Gross margin
70.2%
Net margin
-158.8%
Operating margin
-159.5%
Efficiency
Return on assets
-76.3%
Return on equity
-124.1%
Return on invested capital
-236.1%
Return on capital employed
-102.2%
Return on sales
-158.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TDOC stock price

How has the Teladoc Health stock price performed over time
Intraday
0.29%
1 week
-7.83%
1 month
-13.23%
1 year
-27.61%
YTD
-19.13%
QTD
-24.47%

Financial performance

How have Teladoc Health's revenue and profit performed over time
Revenue
$2.53B
Gross profit
$1.78B
Operating income
-$4.04B
Net income
-$4.02B
Gross margin
70.2%
Net margin
-158.8%
TDOC's net margin has soared by 64% YoY and by 44% from the previous quarter
The operating margin has soared by 64% YoY and by 44% from the previous quarter
TDOC's net income has surged by 59% year-on-year and by 43% since the previous quarter
TDOC's operating income has soared by 59% YoY and by 43% from the previous quarter

Growth

What is Teladoc Health's growth rate over time

Valuation

What is Teladoc Health stock price valuation
P/E
N/A
P/B
1.36
P/S
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.49
The company's EPS has surged by 60% YoY and by 43% QoQ
The stock's price to book (P/B) is 63% less than its 5-year quarterly average of 3.7 and 9% less than its last 4 quarters average of 1.5
Teladoc Health's equity has shrunk by 62% YoY
The P/S is 88% below the 5-year quarterly average of 10.4 and 27% below the last 4 quarters average of 1.7
TDOC's revenue is up by 13% year-on-year and by 2.4% since the previous quarter

Efficiency

How efficient is Teladoc Health business performance
The company's return on sales has surged by 64% YoY and by 44% QoQ
Teladoc Health's return on invested capital has surged by 63% YoY and by 43% QoQ
Teladoc Health's ROE has decreased by 49% YoY but it has increased by 26% from the previous quarter
TDOC's return on assets is up by 33% since the previous quarter but it is down by 6% year-on-year

Dividends

What is TDOC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TDOC.

Financial health

How did Teladoc Health financials performed over time
Teladoc Health's total assets is 114% higher than its total liabilities
Teladoc Health's total assets has decreased by 47% YoY
TDOC's quick ratio is up by 6% since the previous quarter and by 4.4% year-on-year
TDOC's debt is 31% less than its equity
The debt to equity has soared by 165% YoY
Teladoc Health's equity has shrunk by 62% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.